CRIS Current Research Information System

FARINA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.230
EU - Europa 6.263
AS - Asia 2.798
AF - Africa 357
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 19
OC - Oceania 14
Totale 18.706
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.207
GB - Regno Unito 1.763
CN - Cina 1.198
IT - Italia 988
DE - Germania 841
SE - Svezia 798
SG - Singapore 715
UA - Ucraina 530
VN - Vietnam 401
IN - India 332
IE - Irlanda 328
FR - Francia 254
RU - Federazione Russa 252
ZA - Sudafrica 130
EE - Estonia 124
TG - Togo 104
CH - Svizzera 88
FI - Finlandia 69
BG - Bulgaria 51
SC - Seychelles 45
CI - Costa d'Avorio 42
BE - Belgio 35
JP - Giappone 34
GR - Grecia 33
NL - Olanda 25
NG - Nigeria 23
TR - Turchia 22
EU - Europa 21
JO - Giordania 18
CA - Canada 17
AT - Austria 16
IR - Iran 16
RO - Romania 15
BR - Brasile 11
LB - Libano 10
AU - Australia 9
ID - Indonesia 9
DK - Danimarca 8
PL - Polonia 8
CZ - Repubblica Ceca 7
MY - Malesia 7
NO - Norvegia 7
ES - Italia 6
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HK - Hong Kong 4
HU - Ungheria 4
MU - Mauritius 4
PH - Filippine 4
SA - Arabia Saudita 4
BD - Bangladesh 3
CL - Cile 3
CV - Capo Verde 3
CY - Cipro 3
IL - Israele 3
KR - Corea 3
MA - Marocco 3
MX - Messico 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
CR - Costa Rica 2
EC - Ecuador 2
MD - Moldavia 2
EG - Egitto 1
GD - Grenada 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 18.706
Salva come PNG Salva come JPEG
Città #
Southend 1.517
Fairfield 1.344
Ashburn 734
Chandler 682
Woodbridge 645
Singapore 637
Wilmington 570
Seattle 563
Houston 523
Cambridge 415
Princeton 395
Jacksonville 385
Ann Arbor 358
Santa Clara 283
Dublin 259
Boardman 244
Dong Ket 242
Nanjing 167
Bologna 165
Westminster 161
Padova 153
Menlo Park 144
Berlin 123
Turin 108
Lomé 104
San Diego 84
Shenyang 80
Jinan 76
Saint Petersburg 73
Milan 71
Mülheim 68
Helsinki 64
Beijing 62
Nanchang 60
Bern 59
Sofia 51
Changsha 46
Dearborn 46
Abidjan 42
Des Moines 42
Hebei 42
Mahé 42
Guangzhou 41
Florence 36
Tianjin 34
Olalla 33
Brussels 32
Shanghai 31
Los Angeles 30
Tokyo 30
Verona 30
Zhengzhou 29
New York 26
Bremen 25
Jiaxing 25
Ningbo 25
London 24
Redwood City 24
Abeokuta 23
Redmond 22
Kuban 21
Rome 21
Frankfurt am Main 20
Medford 20
Taizhou 20
Amman 18
Haikou 18
Norwalk 18
Hefei 16
Lanzhou 16
Phoenix 16
Wuhan 16
Kunming 15
Taiyuan 15
Bühl 13
Falls Church 13
Hangzhou 13
Munich 13
San Venanzo 13
Fuzhou 12
Paris 12
San Francisco 12
Falkenstein 10
Toronto 10
Vienna 10
Wenzhou 10
Catania 9
Chengdu 9
Shenzhen 9
Washington 9
Istanbul 8
Izmir 8
Jakarta 8
Lausanne 8
Xi'an 8
Amsterdam 7
Corbetta 7
Costa Mesa 7
Groningen 7
Kuala Lumpur 7
Totale 12.951
Salva come PNG Salva come JPEG
Nome #
metodo e kit per la diagnosi prenatale di cardiopatie congenite 438
Fetal cardiac defects and third-trimester maternal serum placental growth factor 197
Circulating mRNA for the PLAC1 Gene as a Second Trimester Marker (14-18 Weeks' Gestation) in the Screening for Late Preeclampsia 184
Intrahepatic Cholestasis of Pregnancy: mRNAs for LIPF and ELOVL4 Genes Are Not Detectable in Circulating Maternal Plasma. 177
Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique 176
Accuracy of fetal gender determination in the first trimester using three-dimensional ultrasound. 176
Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia. 172
Brainstem-vermis and brainstem-tentorium angles allow accurate categorization of fetal upward rotation of cerebellar vermis 168
IN GRAVIDANZE A TERMINE SOTTOPOSTE A INDUZIONE I LIVELLI DELL’mRNA DEL PLAC1 NEL SANGUE MATERNO SONO CORRELATI CON L’INTERVALLO DI TEMPO CHE INTERCORRE TRA LA PRIMA SOMMINISTRAZIONE DI GEL A BASE DI DINOPROSTONE E IL PARTO 165
PLAC1 mRNA in maternal blood correlates with Doppler waveform in uterine arteries in normal pregnancies at the second and third trimester. 164
Heat shock response by EBV-immortalized B-lymphocytes from centenarians and control subjects: A model to study the relevance of stress response in longevity 162
Prenatal diagnosis of a complete mole coexisting with a dichorionic twin pregnancy: case report. 162
Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. 161
Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. 155
P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. 155
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 154
Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. 149
Dynamic changes of fetal head descent at term before the onset of labor correlate with labor outcome and can be improved by ultrasound visual feedback 149
Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis. 147
Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes 145
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 139
Analysis of the ultrasonographic findings predictive of vasa previa. 136
Velamentous cord insertion and atypical variable decelerations with no accelerations. 135
Akt, protein kinase C, and mitogen-activated protein kinase phosphorylation status in head and neck squamous cell carcinoma. 134
Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. 133
Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients 133
The impact of assisted reproductive technology and chorionicity in twin pregnancies complicated by obstetric cholestasis 133
Biophysical markers for abnormal placentation: first and/or second trimester 132
Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. 131
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening. 131
Ultrasound prediction of symptomatic congenital cytomegalovirus infection 130
Congenital heart defects: is it time to explore maternal blood for a non-invasive genetic screening test? 129
Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. 129
Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening. 129
Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction 129
Vaginal cuff dehiscence after hysterectomy: a multicenter retrospective study. 128
Delivery and immigration: the experience of an Italian hospital. 128
Evidence of genetic underexpression in chorionic villi samples of euploid fetuses with increased nuchal translucency at 10-11 weeks' gestation 127
Bcl-2 as prognostic factor in head and neck squamous cell carcinoma. 127
Antioxidant supplementation in pregnant women with low antioxidant status. 126
A First-Trimester Biomarker Panel for Predicting the Development of Gestational Diabetes 126
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening. 125
null 125
Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. 124
Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. 123
Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. 123
PLAC1 mRNA levels in maternal blood at induction of labor correlate negatively with induction-delivery interval. 121
Gene Expression Profile Analysis in Human T Lymphocytes from Patients with Down Syndrome. 119
Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. 119
Umbilical cord insertion into the lower segment of the uterus at 11 to 13 weeks' gestation is associated with maternal serum PAPP-A. 119
Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis 119
An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens 119
Cord insertion into the lower third of the uterus in the first trimester is associated with placental and umbilical cord abnormalities 117
Clinical outcome of 285 Medpor grafts used for craniofacial reconstruction. 117
Circulating mRNA in Maternal Plasma at the Second Trimester of Pregnancy: A Possible Screening Tool for Cardiac Conotruncal and Left Ventricular Outflow Tract Abnormalities 117
Circulating mRNA for epidermal growth factor-like domain 7 (EGFL7) in maternal blood and early intrauterine growth restriction. A preliminary analysis 117
Time remaining in labor and probability of vaginal delivery as a function of the angle of progression in a low risk population with a normal first stage of labor. In-house observational study and comparison with the data in the literature 116
Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. 115
Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta. 115
Rapid clearance of mRNA for PLAC1 gene in maternal blood after delivery. 114
Prospective evaluation of the risk of pre-eclampsia using logistic regression analysis. 114
Elevated maternal placental protein 13 serum levels at term of pregnancy in postpartum major hemorrhage (>1000 mLs). A prospective cohort study 113
Caesarean scar pregnancy complicated by placenta percreta followed by suppurative appendicitis after conservative management with methotrexate 113
Multivariable evaluation of term birth weight: a comparison between ultrasound biometry and symphysis-fundal height 112
PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. 111
Ultrasound screening for congenital pyelectasis in term pregnancies 111
Diagnosis of station and rotation of the fetal head in the second stage of labor with intrapartum translabial ultrasound. 109
Delaire's cheilorhinoplasty: Unilateral cleft aesthetic outcome scored according to the EUROCLEFT guidelines 108
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation 107
Non-syndromic orofacial clefts in Southern Italy: pattern analysis according to gender, history of maternal smoking, folic acid intake and familial diabetes. J Craniomaxillofac Surg. 106
Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. 106
Lower maternal PLAC1 mRNA in pregnancies complicated with vaginal bleeding (threatened abortion <20 weeks) and a surviving fetus. 106
Normal morphometry of fetal posterior fossa at midtrimester: brainstem-tentorium angle and brainstem-vermis angle. 106
The Tei index for evaluation of fetal myocardial performance in sick fetuses 105
Cell-free mRNA concentrations of plasminogen activator inhibitor-1 andtissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. 105
Infezione da HIV e gravidanza: profilassi versus terapia antiretrovirale altamente efficace 105
Predisposing factors for massive hemorrhage during Cesarean section in patients with placenta previa 104
BASSI LIVELLI DI mRNA PER IL GENE PLAC1 NELLE GRAVIDANZE COMPLICATE DA PERDITE EMATICHE VAGINALI (MINACCIA D’ABORTO <20 SETTIMANE) MA CON SOPRAVVIVENZA FETALE 104
Levels of Circulating mRNA for the Tenascin-X (TNXB) Gene in Maternal Plasma at the Second Trimester in Pregnancies with Isolated Congenital Ventricular Septal Defects 104
PLAC1 (Placenta-specific 1): a novel, X-linked gene with roles in reproductive and cancer biology 103
Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation. 103
Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. 102
Development of noninvasive fetal DNA diagnosis from nucleated erythrocytes circulating in maternal blood. 102
TGF Alpha Has Low Protein Expression in Nonsyndromic Clefts. 102
Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation 102
pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance 102
beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. 102
Three-dimensional ultrasound is an accurate and reproducible technique for fetal crown-rump length measureme 102
IMPATTO DELLE INDAGINI DIAGNOSTICHE DI APPROFONDIMENTO E DEL COUNSELLING SULLA PERCENTUALE DI INTERRUZIONI VOLONTARIE DI GRAVIDANZA NELLE DONNE CON RISCONTRO DI IMMUNOGLOBULINE M ANTI-CITOMEGALOVIRUS AL TEST DI SCREENING 101
Clinical potential for noninvasive prenatal diagnosis through detection of fetal cells in maternal blood 101
The First Case Report in Italy of Di George Syndrome Detected by Noninvasive Prenatal Testing 101
Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks. 101
Effect of c-Met expression on survival in head and neck squamous cell carcinoma. 100
PP13 mRNA Expression in Trophoblasts From Preeclamptic Placentas. 100
Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes 99
Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening 98
Correlation between umbilical arterial pH values and fetal vertebral artery Doppler waveforms at the beginning of the second stage of labor: a pilot prospective study 98
Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21. 97
Impatto della HAART(Higly Active Antiretroviral Therapy) sull’outcome delle gravidanze di donne HIV positive in contesti a risorse limitate 97
Sonographic evaluation of the fetal spine position and success rate of manual rotation of the fetus in occiput posterior position: A randomized controlled trial 97
Totale 12.724
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 231
Totale 51.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.851 0 0 0 0 0 0 662 747 631 345 158 308
2020/20212.580 527 222 104 125 68 135 47 186 212 171 168 615
2021/20223.155 201 91 240 359 317 151 86 229 114 185 599 583
2022/20233.300 395 479 193 399 210 236 91 175 490 116 342 174
2023/2024892 94 157 81 94 78 130 45 64 24 49 29 47
2024/20252.058 155 553 318 264 512 249 7 0 0 0 0 0
Totale 19.157